Trials / Completed
CompletedNCT01679483
Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer
THE ROLE OF FLOSEAL IN THE PREVENTION OF LYMPHOCELE AND LYMPHATIC ASCITES AFTER LYMPH NODE DISSECTION FOR GYNECOLOGIC CANCER: A RANDOMIZED CONTROLLED TRIAL
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To compare the incidence of lymphocele and lymphatic ascites between patient who use versus who do not use FloSeal during lymph node dissection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FloSeal application | At the completion of lymph node dissection, 2 vials of Floseal will be applied to each lymph node area. |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2012-09-06
- Last updated
- 2017-05-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01679483. Inclusion in this directory is not an endorsement.